Disclosed is a method for detecting
breast cancer biomarkers, which can be applied in
cancer diagnosis and monitoring the effectiveness of
cancer therapy. This
fiber-optic
biosensor-based approach employs advanced photonic techniques to identify specific biomarkers with high sensitivity and specificity. The technical result is achieved through a
system including a fabricated and biologically functionalized
fiber-optic
biosensor, immersed in a controlled fluidic environment that mimics in situ conditions. The
biosensor is integrated into a commercially available
catheter, which is placed within a flow-through tube containing serum. The work focuses on enhancing biosensor performance under simulated blood-like conditions, including optimization of sensor positioning, packaging modifications, and assessment of specificity and sensitivity under varying pressure levels. The aim is to improve the efficiency, accuracy, and reliability of
cancer biomarker detection, ultimately enabling earlier and more precise diagnosis for patient benefit.